GLP3 Peptide: Advanced Triple Agonist for Metabolic Research

GLP3 Peptide is a sophisticated triple-receptor agonist designed for laboratory research into metabolic pathways. This innovative compound targets GLP-1, GIP, and glucagon receptors simultaneously, making it valuable for scientific studies examining weight regulation, glucose metabolism, and overall metabolic function.

In research settings, GLP3 Peptide demonstrates how triple-pathway activation may produce different results compared to single or dual-agonist compounds. Laboratory studies investigate its mechanisms: GLP-1 pathway effects on appetite signaling and gastric processes, GIP pathway influence on insulin response and lipid metabolism, and glucagon pathway impact on energy utilization and fat oxidation.

Scientific interest in GLP3 Peptide extends to research models of obesity, diabetes, cardiovascular health factors, and non-alcoholic fatty liver disease (NAFLD). The compound is typically studied using subcutaneous administration in controlled laboratory environments.

FOR RESEARCH PURPOSES ONLY Not for human consumption. Not a pharmaceutical, medicine, or dietary supplement. Laboratory use only. By purchasing, you confirm compliance with all applicable regulations regarding research compounds.